TERESA WOLFORD: Open Payments
NPI 1487652541 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,396 in 127 payments from 18 companies in 2025. Trend: 2023 $2,382 · 2024 $2,339 · 2025 $2,396
Food & beverage: $2,396
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $468 |
| AstraZeneca Pharmaceuticals LP | 20 | $392 |
| Amgen Inc. | 11 | $228 |
| PFIZER INC. | 11 | $207 |
| Novo Nordisk Inc | 7 | $178 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $115 |
| Lundbeck LLC | 4 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| Exact Sciences Corporation | 5 | $95 |
Products named: AIRSUPRA, VRAYLAR, UBRELVY, NURTEC ODT, QULIPTA, LEQVIO, Kerendia, Ozempic.
Industry payments across MD — which companies pay providers there.
